After Delpharm bought the Boucherville plant in 2022, Sandoz signed an exclusive partnership with the company to maintain its ...
Twenty U.S. states including California, Connecticut and Michigan have pushed back against a $10 million settlement that Florida reached with Swiss generic drugmaker Sandoz, saying a key provision ...
Switzerland has so far been spared tariff threats from the new US President Donald Trump. Nevertheless, Swiss companies are taking precautions.
Sandoz garners chunky demand for 10 year trade â—† Trend continues for issuers to set deal parameters quickly â—† Single digit ...
Sandoz signs 10-year agreement with partner Delpharm, a global pharmaceutical developer and contract manufacturer Agreement will secure a reliable supply of affordable, quality sterile injectables ...
And as you're about to notice, not only were the pharmaceutical products they created over the years similar, but Ciba, Geigy and Sandoz's histories intertwined long before their final merger in 1996.
TURKU, FINLAND / ACCESS Newswire / March 21, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN)(AIM: FARN) (First North: FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER approach ...
The decision comes in the wake of changes to Novartis' organisational structure, including the merger of its pharmaceuticals ... in October 2021, after Sandoz had been suffering from pressure ...
After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...
Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...